Glucagon is underused for treating severe hypoglycemia in both emergency and outpatient settings, new research suggests. Findings from an analysis of data on glucagon administration by emergency ...

Please provide your email address to receive an email when new articles are posted on . Nasal glucagon was noninferior to intramuscular glucagon for treating hypoglycemia in Japanese adults with type ...

LISBON, PORTUGAL — Minidose glucagon is more effective than insulin reduction for preventing exercise-induced hypoglycemia, according to a new study in patients with type 1 diabetes. "When initiated ...

Please provide your email address to receive an email when new articles are posted on . The FDA on Wednesday approved the first nasal glucagon powder for the emergency treatment of severe hypoglycemia ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of its Glucagon Emergency Kit, an FDA-approved and cost-effective alternative to treat severe ...

SAN DIEGO -- A novel formulation of glucagon administered as a dry mist nasal spray showed real-world effectiveness when administered to treat moderate or severe hypoglycemia in adults with type 1 ...

Glucagon raises the blood glucose concentration by mobilizing hepatic glycogen stores through activation of liver phosphorylase. Because crystalline glucagon is rapidly inactivated once it enters the ...

The NDA included findings from multiple Phase 3 trials evaluating the safety, efficacy, and utility of the Xeris glucagon rescue pen auto-injector to treat severe hypoglycemia vs currently available ...

New findings raise the possibility of promising therapeutic strategies for the management of hypoglycemia in type 1 diabetes patients. Study: Loss of electrical β-cell to δ-cell coupling underlies ...

Hypoglycemia (low blood sugar) treatments will depend on the severity of symptoms and how low the blood sugar level has fallen. Mild hypoglycemia symptoms can be treated with high-sugar foods or ...

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an ...